Aveo Pharmaceuticals, Inc.

This early-stage study is testing a new drug called AV-380, given alongside standard chemotherapy, for patients with advanced cancer who are experiencing severe, unintentional weight and muscle loss (cachexia). The main goal is to find a safe dose and see how the body processes t…